Title : NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.

Pub. Date : 2019

PMID : 30865715






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies. davunetide catenin beta like 1 Homo sapiens
2 Clinically, NAP (davunetide, CP201) exhibited efficacy in prodromal Alzheimer"s disease patients (Tau3R/4R tauopathy) but not in progressive supranuclear palsy (increased Tau4R tauopathy). davunetide catenin beta like 1 Homo sapiens